An in situ ratiometric fluorescence immunosensor via Mn2+-triggered aggregation-induced emission transformation of levodopa fluorescent copolymer nanoparticles

Yifei Ma,Xiaoxue Liu,Naidi Yang,Changpeng Zou,Yujie Sun,Guichuan Xing,Jinhua Liu,Zhihui Xu,Fenghua Geng
DOI: https://doi.org/10.1039/d4ay00973h
2024-10-10
Abstract:Herein, a direct in situ alkaline phosphatase (ALP)-labeled luminescent nanoimmunoassay platform was constructed using Mn2+-triggered aggregation-induced emission transformation of levodopa fluorescent copolymer (LFC) nanoparticles. Using cardiac troponin I (cTn I) as the model antigen, the proposed nanoimmunosensor has been applied to detect cTn I in clinical samples with satisfactory results.
What problem does this paper attempt to address?